LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | - | - | 40.0 | 23.0 | - | - | - | 63 |
1 | - | - | - | - | - | 307.0 | 277.0 | - | - | - | 584 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 2 |
1 | 7 |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 84 |
1 | 490 |
Number of post synapses: 63
Number of pre synapses: 584
Number of output connections: 2530
Coverage factor: 1.0
Columnar completeness: 0.16
Area completeness: 0.29
Cell size (columns): 140
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#MeVPMe6 (L) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | aMe17b (R) | GABA | 8 | 8.0 | 11.9% | 11.9% |
1 | MeVP7 (R) | ACh | 8 | 8.0 | 11.9% | 23.9% |
2 | Cm12 (R) | GABA | 5 | 5.0 | 7.5% | 31.3% |
3 | Cm3 (R) | GABA | 4 | 4.0 | 6.0% | 37.3% |
4 | Cm31b (R) | GABA | 3 | 3.0 | 4.5% | 41.8% |
5 | Cm9 (R) | Glu | 3 | 3.0 | 4.5% | 46.3% |
6 | Mi15 (R) | ACh | 3 | 3.0 | 4.5% | 50.7% |
7 | Cm5 (R) | GABA | 2 | 2.0 | 3.0% | 53.7% |
8 | MeTu3c (R) | ACh | 2 | 2.0 | 3.0% | 56.7% |
9 | OA-AL2i4 (R) | OA | 2 | 2.0 | 3.0% | 59.7% |
10 | 5-HTPMPV03 (L) | 5HT | 1 | 1.0 | 1.5% | 61.2% |
11 | aMe17c (R) | Glu | 1 | 1.0 | 1.5% | 62.7% |
12 | aMe2 (R) | Glu | 1 | 1.0 | 1.5% | 64.2% |
13 | aMe4 (R) | ACh | 1 | 1.0 | 1.5% | 65.7% |
14 | aMe5 (R) | ACh | 1 | 1.0 | 1.5% | 67.2% |
15 | aMe9 (R) | ACh | 1 | 1.0 | 1.5% | 68.7% |
16 | Cm1 (R) | ACh | 1 | 1.0 | 1.5% | 70.1% |
17 | Cm10 (R) | GABA | 1 | 1.0 | 1.5% | 71.6% |
18 | Cm21 (R) | GABA | 1 | 1.0 | 1.5% | 73.1% |
19 | Cm30 (R) | GABA | 1 | 1.0 | 1.5% | 74.6% |
20 | Cm6 (R) | GABA | 1 | 1.0 | 1.5% | 76.1% |
21 | Cm7 (R) | Glu | 1 | 1.0 | 1.5% | 77.6% |
22 | Cm8 (R) | GABA | 1 | 1.0 | 1.5% | 79.1% |
23 | Cm_unclear (R) | ACh | 1 | 1.0 | 1.5% | 80.6% |
24 | Dm2 (R) | ACh | 1 | 1.0 | 1.5% | 82.1% |
25 | DNc01 (R) | unclear | 1 | 1.0 | 1.5% | 83.6% |
26 | MeLo3a (R) | ACh | 1 | 1.0 | 1.5% | 85.1% |
27 | MeLo4 (R) | ACh | 1 | 1.0 | 1.5% | 86.6% |
28 | MeTu1 (R) | ACh | 1 | 1.0 | 1.5% | 88.1% |
29 | MeTu4c (R) | ACh | 1 | 1.0 | 1.5% | 89.6% |
30 | MeVC10 (L) | ACh | 1 | 1.0 | 1.5% | 91.0% |
31 | MeVP1 (R) | ACh | 1 | 1.0 | 1.5% | 92.5% |
32 | MeVP2 (R) | ACh | 1 | 1.0 | 1.5% | 94.0% |
33 | MeVP6 (R) | Glu | 1 | 1.0 | 1.5% | 95.5% |
34 | Mi10 (R) | ACh | 1 | 1.0 | 1.5% | 97.0% |
35 | Tm38 (R) | ACh | 1 | 1.0 | 1.5% | 98.5% |
36 | TmY5a (R) | Glu | 1 | 1.0 | 1.5% | 100.0% |
instance | NT | total connections | connections /#MeVPMe6 (L) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | MeVP7 (R) | ACh | 372 | 372.0 | 14.5% | 14.5% |
1 | Cm6 (R) | GABA | 326 | 326.0 | 12.7% | 27.2% |
2 | Cm3 (R) | GABA | 286 | 286.0 | 11.1% | 38.3% |
3 | Cm12 (R) | GABA | 180 | 180.0 | 7.0% | 45.3% |
4 | aMe9 (R) | ACh | 165 | 165.0 | 6.4% | 51.7% |
5 | Cm5 (R) | GABA | 139 | 139.0 | 5.4% | 57.1% |
6 | Cm8 (R) | GABA | 138 | 138.0 | 5.4% | 62.5% |
7 | MeTu1 (R) | ACh | 77 | 77.0 | 3.0% | 65.5% |
8 | Mi15 (R) | ACh | 76 | 76.0 | 3.0% | 68.5% |
9 | Cm23 (R) | Glu | 69 | 69.0 | 2.7% | 71.2% |
10 | MeTu4f (R) | ACh | 54 | 54.0 | 2.1% | 73.3% |
11 | Cm31b (R) | GABA | 46 | 46.0 | 1.8% | 75.0% |
12 | aMe5 (R) | ACh | 42 | 42.0 | 1.6% | 76.7% |
13 | Cm_unclear (R) | ACh | 40 | 40.0 | 1.6% | 78.2% |
14 | Tm37 (R) | Glu | 35 | 35.0 | 1.4% | 79.6% |
15 | Cm33 (R) | GABA | 33 | 33.0 | 1.3% | 80.9% |
16 | aMe10 (R) | ACh | 31 | 31.0 | 1.2% | 82.1% |
17 | Cm13 (R) | Glu | 30 | 30.0 | 1.2% | 83.3% |
18 | TmY10 (R) | ACh | 30 | 30.0 | 1.2% | 84.4% |
19 | MeVP29 (R) | ACh | 28 | 28.0 | 1.1% | 85.5% |
20 | Cm7 (R) | Glu | 26 | 26.0 | 1.0% | 86.5% |
21 | MeVP59 (R) | ACh | 23 | 23.0 | 0.9% | 87.4% |
22 | Cm9 (R) | Glu | 20 | 20.0 | 0.8% | 88.2% |
23 | MeVP8 (R) | ACh | 17 | 17.0 | 0.7% | 88.9% |
24 | MeTu4d (R) | ACh | 16 | 16.0 | 0.6% | 89.5% |
25 | MeTu3c (R) | ACh | 14 | 14.0 | 0.5% | 90.0% |
26 | MeVP21 (R) | ACh | 13 | 13.0 | 0.5% | 90.5% |
27 | C2 (R) | GABA | 10 | 10.0 | 0.4% | 90.9% |
28 | MeVP40 (R) | unclear | 10 | 10.0 | 0.4% | 91.3% |
29 | MeVP9 (R) | ACh | 10 | 10.0 | 0.4% | 91.7% |
30 | Tm33 (R) | ACh | 9 | 9.0 | 0.4% | 92.1% |
31 | aMe30 (R) | Glu | 8 | 8.0 | 0.3% | 92.4% |
32 | Cm35 (R) | GABA | 8 | 8.0 | 0.3% | 92.7% |
33 | MeLo3a (R) | ACh | 8 | 8.0 | 0.3% | 93.0% |
34 | Tm39 (R) | ACh | 8 | 8.0 | 0.3% | 93.3% |
35 | Tm5Y (R) | ACh | 8 | 8.0 | 0.3% | 93.6% |
36 | MeLo4 (R) | ACh | 7 | 7.0 | 0.3% | 93.9% |
37 | Tm34 (R) | Glu | 7 | 7.0 | 0.3% | 94.2% |
38 | LT58 (R) | Glu | 6 | 6.0 | 0.2% | 94.4% |
39 | MeVP2 (R) | ACh | 6 | 6.0 | 0.2% | 94.6% |
40 | aMe17b (R) | GABA | 5 | 5.0 | 0.2% | 94.8% |
41 | Cm11c (R) | ACh | 5 | 5.0 | 0.2% | 95.0% |
42 | Dm2 (R) | ACh | 5 | 5.0 | 0.2% | 95.2% |
43 | MeVP1 (R) | ACh | 5 | 5.0 | 0.2% | 95.4% |
44 | SLP250 (R) | unclear | 5 | 5.0 | 0.2% | 95.6% |
45 | Tm36 (R) | ACh | 5 | 5.0 | 0.2% | 95.8% |
46 | Cm14 (R) | GABA | 4 | 4.0 | 0.2% | 96.0% |
47 | Cm15 (R) | GABA | 4 | 4.0 | 0.2% | 96.1% |
48 | Cm25 (R) | Glu | 4 | 4.0 | 0.2% | 96.3% |
49 | Cm30 (R) | GABA | 4 | 4.0 | 0.2% | 96.4% |
50 | MeVP6 (R) | Glu | 4 | 4.0 | 0.2% | 96.6% |
51 | MeVPMe9 (R) | Glu | 4 | 4.0 | 0.2% | 96.7% |
52 | TmY17 (R) | ACh | 4 | 4.0 | 0.2% | 96.9% |
53 | aMe15 (R) | unclear | 3 | 3.0 | 0.1% | 97.0% |
54 | Cm17 (R) | GABA | 3 | 3.0 | 0.1% | 97.1% |
55 | Cm31a (R) | GABA | 3 | 3.0 | 0.1% | 97.2% |
56 | MeTu4c (R) | ACh | 3 | 3.0 | 0.1% | 97.4% |
57 | MeVPMe12 (R) | ACh | 3 | 3.0 | 0.1% | 97.5% |
58 | Mi18 (R) | GABA | 3 | 3.0 | 0.1% | 97.6% |
59 | Mi9 (R) | Glu | 3 | 3.0 | 0.1% | 97.7% |
60 | Tm30 (R) | GABA | 3 | 3.0 | 0.1% | 97.8% |
61 | TmY18 (R) | ACh | 3 | 3.0 | 0.1% | 97.9% |
62 | TmY4 (R) | ACh | 3 | 3.0 | 0.1% | 98.1% |
63 | aMe10 (L) | ACh | 2 | 2.0 | 0.1% | 98.1% |
64 | Cm10 (R) | GABA | 2 | 2.0 | 0.1% | 98.2% |
65 | Cm21 (R) | GABA | 2 | 2.0 | 0.1% | 98.3% |
66 | Cm26 (R) | Glu | 2 | 2.0 | 0.1% | 98.4% |
67 | MeVP33 (R) | ACh | 2 | 2.0 | 0.1% | 98.4% |
68 | MeVP42 (R) | ACh | 2 | 2.0 | 0.1% | 98.5% |
69 | MeVPaMe1 (R) | ACh | 2 | 2.0 | 0.1% | 98.6% |
70 | Pm8 (R) | GABA | 2 | 2.0 | 0.1% | 98.7% |
71 | Tm38 (R) | ACh | 2 | 2.0 | 0.1% | 98.8% |
72 | Tm6 (R) | ACh | 2 | 2.0 | 0.1% | 98.8% |
73 | 5thsLNv_LNd6 (R) | ACh | 1 | 1.0 | 0.0% | 98.9% |
74 | aMe17c (R) | Glu | 1 | 1.0 | 0.0% | 98.9% |
75 | aMe4 (R) | ACh | 1 | 1.0 | 0.0% | 98.9% |
76 | Cm29 (R) | GABA | 1 | 1.0 | 0.0% | 99.0% |
77 | Cm34 (R) | Glu | 1 | 1.0 | 0.0% | 99.0% |
78 | Lat1 (R) | unclear | 1 | 1.0 | 0.0% | 99.1% |
79 | LT88 (R) | Glu | 1 | 1.0 | 0.0% | 99.1% |
80 | MeVC10 (L) | ACh | 1 | 1.0 | 0.0% | 99.1% |
81 | MeVC20 (R) | Glu | 1 | 1.0 | 0.0% | 99.2% |
82 | MeVC21 (R) | Glu | 1 | 1.0 | 0.0% | 99.2% |
83 | MeVP10 (R) | ACh | 1 | 1.0 | 0.0% | 99.3% |
84 | MeVP11 (R) | ACh | 1 | 1.0 | 0.0% | 99.3% |
85 | MeVP22 (R) | GABA | 1 | 1.0 | 0.0% | 99.3% |
86 | MeVP25 (R) | unclear | 1 | 1.0 | 0.0% | 99.4% |
87 | MeVP3 (R) | ACh | 1 | 1.0 | 0.0% | 99.4% |
88 | MeVP41 (R) | ACh | 1 | 1.0 | 0.0% | 99.5% |
89 | MeVP43 (R) | ACh | 1 | 1.0 | 0.0% | 99.5% |
90 | MeVPMe11 (L) | Glu | 1 | 1.0 | 0.0% | 99.5% |
91 | MeVPMe13 (L) | ACh | 1 | 1.0 | 0.0% | 99.6% |
92 | MeVPMe2 (R) | Glu | 1 | 1.0 | 0.0% | 99.6% |
93 | MeVPMe4 (R) | Glu | 1 | 1.0 | 0.0% | 99.6% |
94 | MeVPMe5 (R) | Glu | 1 | 1.0 | 0.0% | 99.7% |
95 | OA-AL2i4 (R) | OA | 1 | 1.0 | 0.0% | 99.7% |
96 | OLVC2 (L) | GABA | 1 | 1.0 | 0.0% | 99.8% |
97 | Pm10 (R) | GABA | 1 | 1.0 | 0.0% | 99.8% |
98 | Tm1 (R) | ACh | 1 | 1.0 | 0.0% | 99.8% |
99 | Tm12 (R) | ACh | 1 | 1.0 | 0.0% | 99.9% |
100 | Tm29 (R) | Glu | 1 | 1.0 | 0.0% | 99.9% |
101 | Tm31 (R) | Glu | 1 | 1.0 | 0.0% | 100.0% |
102 | Tm5c (R) | Glu | 1 | 1.0 | 0.0% | 100.0% |